LYRA THERAPEUTICS, INC.
Profile
Company Names
LYRA THERAPEUTICS, INC.
480 BIOMEDICAL, INC.
ARSENAL VASCULAR, INC.
ARSENAL MEDICAL, INC.
Addresses
480 ARSENAL WAY, WATERTOWN, MA 02472
480 ARSENAL STREET, WATERTOWN, MA 02472
Phone Numbers
617-373-4600
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER
Year Incorporated:
2005
State Incorporated:
DE
Total Amount Raised:
$246,868,922.00
Number of Funding Rounds:
13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2023-05-25
$50,000,008.00
$50,000,008.00
$0.00
Equity
12
2022-04-12
$100,494,970.00
$100,494,970.00
$0.00
Equity
11
2020-01-10
$28,049,999.00
$28,049,999.00
$0.00
Equity
10
2016-11-10
$5,999,999.00
$5,999,999.00
$0.00
Equity
9
2013-03-29
$17,956,999.00
$21,213,551.00
$3,256,552.00
Equity
8
2012-10-15
$5,078,139.00
$6,000,000.00
$921,861.00
Debt
7
2011-10-24
$3,000,000.00
$3,000,000.00
$0.00
Equity
6
2011-09-07
$12,000,000.00
$18,000,002.00
$6,000,002.00
Equity
5
2010-07-30
$3,000,000.00
$3,000,000.00
$0.00
Debt
4
2010-05-13
$10,051,308.00
$10,051,308.00
$0.00
Equity
3
2010-03-19
$1,000,000.00
$1,000,000.00
$0.00
Debt
2
2010-01-14
$2,050,000.00
$2,050,000.00
$0.00
Debt
1
2009-04-03
$8,187,500.00
$12,187,500.00
$4,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
ALTMAN
DIRECTOR
WAYPOINT CAMERON INVESTORS, LP
| CORTLAND PARTNERS FUND II, LLC
| CORTLAND PORTFOLIO 12 COINVEST LLC
| CORTLAND PARTNERS FUND III, LLC
| RIVERTOWN THERAPEUTICS, INC.
| VENSUN PHARMACEUTICALS, INC.
| CORTLAND PARTNERS FUND IV, LLC
| VITRUVIAS THERAPEUTICS, INC.
| LYRA THERAPEUTICS, INC.
| NAUTILUS BIOTECHNOLOGY, INC.
EDWARD
ANDERSON
DIRECTOR
EARL
M.
COLLIER, JR.
EXECUTIVE OFFICER, DIRECTOR
DENNIS
DOUGHERTY
DIRECTOR
JAMES
GOLDSTEIN
DIRECTOR
ROBERT
LANGER
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ALSERES PHARMACEUTICALS INC /DE
| ECHO THERAPEUTICS, INC.
| MICELL TECHNOLOGIES INC
| CERULEAN PHARMA INC.
| HUMACYTE INC
| COMBINENT BIOMEDICAL SYSTEMS, INC.
| TARIS BIOMEDICAL INC
| KALA PHARMACEUTICALS, INC.
| FIBROCELL SCIENCE, INC.
| PREDICTIVE BIOSCIENCES, INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| SEMPRUS BIOSCIENCES CORP
| LIQUIDX, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| SELECTA BIOSCIENCES INC
| STEMNION, INC.
| 480 BIOMEDICAL, INC.
| LIVING PROOF INC
| DX BIOSCIENCES, INC.
| MODERNA LLC
| HUMACYTE, INC
| XTUIT PHARMACEUTICALS, INC.
| SQZ BIOTECHNOLOGIES CO
| NOVEOME BIOTHERAPEUTICS, INC.
| LYNDRA, INC.
| MODERNA THERAPEUTICS, INC.
| VERSEAU THERAPEUTICS, INC.
| FREQUENCY THERAPEUTICS, INC.
| SUONO BIO, INC.
| COMBINED THERAPEUTICS, INC.
| HUMACYTE, INC.
| SEER BIOSCIENCES, INC.
| LANDSDOWNE LABS, LLC
| LIKEMINDS, INC./DE
| TARVEDA THERAPEUTICS, INC.
| LUMINOPIA, INC.
| LYRA THERAPEUTICS, INC.
| ABPRO CORP
| GLYMPSE BIO, INC.
| EPIBONE, INC.
| TEAL BIO, INC.
| ZWI THERAPEUTICS, INC.
| LYNDRA THERAPEUTICS, INC.
| KENDALL CAPITAL PARTNERS I, L.P.
| BILAYER THERAPEUTICS, INC.
| XENTER, INC.
| VIVTEX CORP
| SYNTIS BIO, INC.
| OMNIPULSE BIOSCIENCES, INC.
TERRANCE
MCGUIRE
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, INC.
| ARSANIS, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, LLC
| 480 BIOMEDICAL, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ICELANDIC PROVISIONS, INC.
| SEER BIOSCIENCES, INC.
| CYCLERION THERAPEUTICS, INC.
| ANKYRA THERAPEUTICS, INC.
| ADAGIO THERAPEUTICS, INC.
| FARADAY PHARMACEUTICALS, INC.
| TECTONIC THERAPEUTIC, INC.
ANN
MERRIFIELD
DIRECTOR
RICHARD
MOTT
DIRECTOR
GUIDO
NEELS
DIRECTOR
KONSTANTIN
POUKALOV
DIRECTOR
CARMICHAEL
ROBERTS
DIRECTOR
ARSENAL MEDICAL, INC.
| ANCORA PHARMACEUTICALS INC
| MC10, INC.
| SENSABLE TECHNOLOGIES INC
| 1366 TECHNOLOGIES INC
| NANO TERRA, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| PAULIE HARRAKA LLC
| 480 BIOMEDICAL, INC.
| COOL PLANET ENERGY SYSTEMS, INC.
| ZERO MASS WATER, INC.
| MATERIAL IMPACT FUND II, L.P.
| DATACULE INC.
| INFINITE COOLING INC.
| CUBICPV INC.
| GALY CO.
| SOURCE GLOBAL, PBC
| MATERIAL IMPACT FUND III, L.P.
| FOUNDATION ALLOY TECHNOLOGY EXPLORATIONS, INC.
| STOICHEIA, INC.
| SOFT ROBOTICS INC.
| MATERIAL IMPACT OPPORTUNITY FUND I, L.P.
| MAGLEV AERO INC.
| BEV FOLLOW-ON FUND I, LLC
| ONEWORLD BEV FUND, L.P.
| FLEET ROBOTICS, INC.
CARMICHAEL
S.
ROBERTS
DIRECTOR
JAMES
ROSEN
DIRECTOR
JAMES
R.
TOBIN
DIRECTOR
GEORGE
WHITESIDES
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2023-05-25
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2022-04-12
D
OTHER
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2020-01-10
